Labcorp (LH)
(Delayed Data from NYSE)
$216.00 USD
+0.93 (0.43%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $216.01 +0.01 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth F Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$216.00 USD
+0.93 (0.43%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $216.01 +0.01 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth F Momentum B VGM
Zacks News
ABIOMED Unveils Digital Platform CAMP PCI for CAD Treatment
by Zacks Equity Research
ABIOMED's (ABMD) new digital platform helps to deliver better patient outcomes for those suffering from CAD.
Here's Why You Should Hold on to Intuitive Surgical Stock Now
by Zacks Equity Research
Intuitive Surgical (ISRG) continues to benefit from rising da Vinci Surgical System, strong international presence and robust recurring revenue base.
AMN Healthcare (AMN) Introduces New Customizable Offering
by Zacks Equity Research
AMN Healthcare (AMN) offers a customizable return-to-work solutions as businesses resume operations amid the ongoing pandemic.
Here's Why You Should Add AngioDynamics to Your Portfolio
by Zacks Equity Research
AngioDynamics (ANGO) continues to benefit from strategic buyouts and strong product portfolio.
HMS Holdings' Solution to Help Consumers Amid Coronavirus
by Zacks Equity Research
HMS Holdings (HMSY) offers a unique COVID-19 health management and communications solution to support consumers during the pandemic.
Zacks.com featured highlights include: Helen of Troy, eBay, Laboratory Corporation of America, ParkerHannifin and Bayer AG
by Zacks Equity Research
Zacks.com featured highlights include: Helen of Troy, eBay, Laboratory Corporation of America, ParkerHannifin and Bayer AG
Here's Why You Should Add LabCorp (LH) Stock to Your Portfolio
by Zacks Equity Research
Investors continue to be optimistic about LabCorp (LH) on increasing demand for COVID-19 tests as well as robust first-quarter 2020 results.
5 PEG-Based Value Stocks to Buy Amid the Coronavirus Crisis
by Urmimala Biswas
While P/E alone fails to identify a true value stock, PEG helps to find the intrinsic value of a stock.
Diagnostic Testing Remains Crucial in Combatting Coronavirus
by Trina Mukherjee
Let's keep a watch on three stocks that are focused on offering advanced diagnostic testing to fight against coronavirus.
LabCorp's New Website Offers Patients Coronavirus Trial Details
by Zacks Equity Research
LabCorp's (LH) Covance business benefits from collaborations with leading pharmaceutical and biotechnology companies.
Surging Earnings Estimates Signal Upside for LabCorp (LH) Stock
by Zacks Equity Research
LabCorp (LH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
LH vs. ALGN: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
LH vs. ALGN: Which Stock Is the Better Value Option?
LabCorp (LH) Up 6.8% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
LabCorp (LH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
LabCorp Partners With Medable to Expand Technology Ecosystem
by Zacks Equity Research
LabCorp (LH) expands technology ecosystem to accelerate the adoption of decentralized clinical trials by collaborating with Medable.
LabCorp's (LH) Q1 Earnings Beat Estimates, Margins Down
by Urmimala Biswas
LabCorp's (LH) Covance Drug Development revenues improve despite COVID-19 hurdles.
LabCorp (LH) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
LabCorp (LH) delivered earnings and revenue surprises of 34.66% and 3.89%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Medical Products Stock Earnings on Apr 29: BSX, ALGN & More
by Urmimala Biswas
Many Medical Product stocks might have succeeded in mitigating coronavirus-led downsides banking on huge market adoption of their COVID-19-related healthcare-support products.
LabCorp (LH) Looks Good: Stock Adds 9% in Session
by Zacks Equity Research
LabCorp (LH) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.
3 Medical Product Stocks Set to Beat This Earnings Season
by Urmimala Biswas
Here we discuss three medical product stocks that are due to report soon and are likely to beat estimates on earnings, riding on a host of factors.
The Zacks Analyst Blog Highlights: PayPal, International Business Machines, Fresenius Medical Care, Laboratory Corp. of America and Insulet
by Zacks Equity Research
The Zacks Analyst Blog Highlights: PayPal, International Business Machines, Fresenius Medical Care, Laboratory Corp. of America and Insulet
Earnings Preview: LabCorp (LH) Q1 Earnings Expected to Decline
by Zacks Equity Research
LabCorp (LH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Economic Data Deluge
by Zacks Equity Research
Economic Data Deluge
Crude Oil Rebounds, New COVID Tests & Q1 Earnings
by Mark Vickery
The Dow looks to open up around 400 points, with the Nasdaq +175 and the S&P 500 +50. The Dow had lost over 1100 points total in the first two trading sessions this week.
Top Stock Reports for PayPal, IBM & Fresenius Medical
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including PayPal (PYPL), International Business Machines (IBM) and Fresenius Medical Care (FMS).
Will LabCorp's (LH) Coronavirus Test Boost Q1 Earnings?
by Zacks Equity Research
LabCorp (LH) is expected to have witnessed a significant fall in its quarterly revenues due to the coronavirus mayhem.